| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Pentoxifylline Impurity J |
己酮可可堿雜質(zhì)J |
874747-30-5 |
詳細(xì)
|
| Minocycline Impurity 2 |
米諾環(huán)素雜質(zhì)2 |
1075240-33-3 |
詳細(xì)
|
| Atorvastatin impurity Ⅷ |
阿托伐他汀鈣雜質(zhì)Ⅷ |
1105067-88-6 |
詳細(xì)
|
| 4-Amino-3-(4-hydroxyphenyl)butyric acid |
4-氨基-3-(4-羥基苯基)丁酸 |
28311-44-6 |
詳細(xì)
|
| Vitamin B6 EP Impurity A |
維生素B6雜質(zhì)A |
5196-20-3 |
詳細(xì)
|
| Niergoline nitrogen oxide impurity 1 |
尼麥角林氮氧化雜質(zhì)1 |
2061916-37-6 |
詳細(xì)
|
| O-dimethylaminophenol |
鄰二甲氨基苯酚 |
3743-22-4 |
詳細(xì)
|
| p-Dimethylaminophenol |
對二甲氨基苯酚 |
619-60-3 |
詳細(xì)
|
| 3-Methoxy-N,N,N-trimethylaniline methanesulfate |
3-甲氧基-N,N,N-三甲基苯胺甲硫酸鹽 |
39218-17-2 |
詳細(xì)
|
| Thioctic Acid Impurity E |
硫辛酸雜質(zhì)E |
728854-75-9 |
詳細(xì)
|
| Thioctic Acid Impurity I |
硫辛酸雜質(zhì)I |
17370-41-1 |
詳細(xì)
|
| Tadalafil Impurity20 |
他達(dá)拉非雜質(zhì)20 |
406938-39-4 |
詳細(xì)
|
| Tadalafil Impurity120 |
他達(dá)拉非雜質(zhì)120 |
1158945-78-8 |
詳細(xì)
|
| Tadalafil standard HCl |
他達(dá)拉非標(biāo)準(zhǔn)品HCl |
1609374-53-9 |
詳細(xì)
|
| 4-Guanidobutyric acid |
4-胍基丁酸 |
463-00-3 |
詳細(xì)
|
| 1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid |
1,2,3,4-四氫-β-咔啉-3-羧酸 |
6052-68-2 |
詳細(xì)
|
| L-pyroglutamyl-L-alanine |
L-焦谷氨酰-L-丙氨酸 |
21282-08-6 |
詳細(xì)
|
| Methacholine Chloride |
氯醋甲膽堿 |
62-51-1 |
詳細(xì)
|
| Triamcinolone Acetonide EP Impurity D |
曲安奈德EP雜質(zhì)D |
10392-74-2 |
詳細(xì)
|
| Dodecyl Ethyl Sulfid |
十二烷基乙基磺酸 |
2851-83-4 |
詳細(xì)
|
| Sitagliptin Impurity 174 |
西他列汀雜質(zhì)174 |
2892260-32-9 |
詳細(xì)
|
| 1,11(4H,5H)-Naphthacenedione, 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-4a,5a,6,12a-tetrahydro-3,10,12,12a-tetrahydroxy-, (4S,4aS,5aR,12aS)- |
奧馬環(huán)素雜質(zhì)14 |
2272886-34-5 |
詳細(xì)
|
| 2-Propanone, O-(methylsulfonyl)oxime |
丙酮肟-O-甲基磺酸酯 |
86921-62-2 |
詳細(xì)
|
| 4-[1-(2-ethoxy-methyl)-1H-benzimidazol-2-yl]-piperidin-1-carboxyic acid tert-butyl ester |
4-[1-(2-乙氧基-甲基)-1H-苯并咪唑-2-基]-哌啶-1-甲酸叔丁酯 |
|
詳細(xì)
|
| (2,4-Dibromo-5-fluorophenyl)benzyl carbamate |
(2,4-二溴-5-氟苯基)氨基甲酸芐酯 |
|
詳細(xì)
|
| Cefuroxime polymer impurities |
頭孢呋辛聚合物雜質(zhì) |
|
詳細(xì)
|
| Piribedil impurity D |
吡貝地爾雜質(zhì)D |
|
詳細(xì)
|
| Sodium Oxagoli Impurity 15 |
噁拉戈利鈉雜質(zhì)15 |
|
詳細(xì)
|
| Raltitrexed impurity K |
雷替曲塞雜質(zhì)K |
|
詳細(xì)
|
| Stiripentol Impurity 3 |
司替戊醇雜質(zhì)3 |
144850-45-3 |
詳細(xì)
|
| Rabeprazole Impurity R |
雷貝拉唑鈉雜質(zhì)R |
153259-31-5 |
詳細(xì)
|
| 3,7-Dimethyl-1-octen-3-ol |
3,7-二甲基-1-辛烯-3-醇 |
18479-49-7 |
詳細(xì)
|
| Bupropion-d9 HCl |
鹽酸安非他酮-D9 |
1189725-26-5 |
詳細(xì)
|
| Dextromethorphan-D6 |
右美沙芬-D6 |
1079043-55-2 |
詳細(xì)
|
| Imatinib Impurity J |
伊馬替尼雜質(zhì)J |
123367-26-0 |
詳細(xì)
|
| Methylaminoformyl chloride |
甲胺基甲酰氯 |
6452-47-7 |
詳細(xì)
|
| Montelukast Impurity J |
孟魯司特鈉雜質(zhì)J |
1258428-71-5 |
詳細(xì)
|
| Naltrexone Impurity I |
納曲酮雜質(zhì)I |
96445-14-6 |
詳細(xì)
|
| Naltrexone Impurity E |
納洛酮雜質(zhì)E |
767615-69-0 |
詳細(xì)
|
| Midazolam EP Impurity I |
咪達(dá)唑侖EP雜質(zhì)I |
59467-69-5 |
詳細(xì)
|
| Midazolam EP Impurity G |
咪達(dá)唑侖EP雜質(zhì)G |
59467-86-6 |
詳細(xì)
|
| Midazolam EP Impurity A |
咪達(dá)唑侖EP雜質(zhì)A |
59468-07-4 |
詳細(xì)
|
| Midazolam EP Impurity J |
咪達(dá)唑侖EP雜質(zhì)J |
59469-08-8 |
詳細(xì)
|
| 4,6-Dichloro-5-phenylpyrimidine |
4,6-二氯-5-苯基嘧啶 |
3974-16-1 |
詳細(xì)
|
| 4,6-dichloro-5-(4-chlorophenyl)-pyriMidine |
4,6-二氯-5-(4-氯苯基)-嘧啶 |
3974-18-3 |
詳細(xì)
|
| Esmolol hydrochloride impurity IV-7 |
鹽酸艾司洛爾雜質(zhì)IV-7 |
343785-33-1 |
詳細(xì)
|
| (2S,4R)-N-(2,6-xylene)-4-methyl-1-(o-toluene)-5-oxo-3-propyl-imidazole-2-carboxamide
(2R,4S)-N-(2,6-xylene)-4-methyl-1-(o-toluene)-5-oxo-3-propyl-imidazole-2-carboxamide |
（2S,4R）-N-（2,6-二甲苯）-4-甲基-1-（鄰甲苯）-5-氧-3-丙基-咪唑-2-甲酰胺
（2R,4S）-N-（2,6-二甲苯）-4-甲基-1-（鄰甲苯）-5-氧-3-丙基-咪唑-2-甲酰胺 |
2815498-43-0 |
詳細(xì)
|
| (R)-oxiran-2-ylmethyl butyrate |
(R)-(-)-縮水甘油丁酸酯 |
60456-26-0 |
詳細(xì)
|
| (3-Fluorophenyl)carbamic acid benzyl ester |
(3-氟苯基)氨基甲酸芐酯 |
149524-47-0 |
詳細(xì)
|
| 5-broMo-2-(2-Methyl-2H-tetrazol-5-yl)pyridine |
2-甲基-5-(5-溴吡啶-2-基)四氮唑 |
380380-64-3 |
詳細(xì)
|
| (5R)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one |
(5R)-3-(4-溴-3-氟苯基)-5-羥甲基噁唑烷-2-酮 |
444335-16-4 |
詳細(xì)
|
| Dolutegravir Impurity 75 |
多替拉韋雜質(zhì)75 |
|
詳細(xì)
|
| Captopril IMpurity I |
卡托普利雜質(zhì)I |
|
詳細(xì)
|
| N-Nitroso-Perindopril |
N-亞硝基培哚普利 |
|
詳細(xì)
|
| Zopiclone Impurity 1 |
佐匹克隆雜質(zhì)1 |
1348046-61-6 |
詳細(xì)
|
| Boc-leucyl-leucine (R)(R) configuration |
Boc-亮氨酰-亮氨酸 (R)(R)構(gòu)型 |
863781-36-6 |
詳細(xì)
|
| Letermovir Impurity 24 |
萊特莫韋雜質(zhì)24 |
2758792-73-1 |
詳細(xì)
|
| Finerenone impurity 147 |
非奈利酮雜質(zhì)147 |
1261439-08-0 |
詳細(xì)
|
| Deferasirox Impurity E |
地拉羅司雜質(zhì)E |
201530-79-2 |
詳細(xì)
|
| Benidipine hydrochloride impurity 21 |
鹽酸貝尼地平雜質(zhì)21 |
118431-03-1 |
詳細(xì)
|
| Cilostazol Related Compound B |
西洛他唑USP相關(guān)化合物B |
73963-62-9 |
詳細(xì)
|
| Lodoxamide Impurity E |
洛度沙胺雜質(zhì)E |
67451-38-1 |
詳細(xì)
|
| Lodoxamide Impurity C |
洛度沙胺雜質(zhì)C |
67451-36-9 |
詳細(xì)
|
| N-Nitroso-Diclofenac |
N-亞硝基雙氯芬酸 |
66505-80-4 |
詳細(xì)
|
| 2-Chloro-4-hydroxypyrimidine |
2-氯-4-羥基嘧啶 |
55873-09-1 |
詳細(xì)
|
| Lodoxamide Impurity B |
洛度沙胺雜質(zhì)B |
53882-26-1 |
詳細(xì)
|
| Piribedil Impurity 1 |
吡貝地爾雜質(zhì)1 |
50602-50-1 |
詳細(xì)
|
| Dronedarone hydrochloride SM2 |
鹽酸決奈達(dá)隆SM2 |
36421-15-5 |
詳細(xì)
|
| Dronedarone hydrochloride SM2-C |
鹽酸決奈達(dá)隆SM2-C |
2050-51-3 |
詳細(xì)
|
| D-Glucosone |
D-葡萄糖醛酮 |
1854-25-7 |
詳細(xì)
|
| Tricaprin |
癸酸甘油三酯 |
621-71-6 |
詳細(xì)
|
| 4-(Trifluoromethyl)benzyl bromide |
4-三氟甲基芐溴 |
402-49-3 |
詳細(xì)
|
| 7-Ethyl-10-hydroxycamptothecin |
7-乙基-10-羥基喜樹堿 |
130144-34-2 |
詳細(xì)
|
| Nateglinide Impurity F |
那格列奈雜質(zhì)F |
944746-48-9 |
詳細(xì)
|
| Nateglinide Impurity E |
那格列奈雜質(zhì)E |
105746-45-0 |
詳細(xì)
|
| 2,6-Dichloro-4-nitrosophenol |
2,6-二氯-4-亞硝基苯酚 |
17277-19-9 |
詳細(xì)
|
| (2-bromo-3-fluorophenyl)benzyl carbamate |
(2-溴-3-氟苯基)氨基甲酸芐酯 |
2295578-89-9 |
詳細(xì)
|
| Benzyl (2-Bromo-5-fluorophenyl)carbamate |
(2-溴-5-氟苯基)氨基甲酸芐酯 |
1643796-25-1 |
詳細(xì)
|
| Fenofibrate choline impurity C |
非諾貝特酸膽堿雜質(zhì)C |
217636-48-1 |
詳細(xì)
|
| 2,5-Dichloropyrimidin-4-ol |
2,5-二氯嘧啶-4-醇（鈉鹽） |
169557-02-2 |
詳細(xì)
|
| (R)-3-((4-bromo-3-fluorophenyl)amino)propane-1,2-diol |
(R)-3-((4-溴-3-氟苯基)氨基)丙烷-1,2-二醇 |
1551262-90-8 |
詳細(xì)
|
| (S) -3- (4-bromo-3-fluorophenyl) -5-hydroxymethyloxazolidin-2-one |
(S)-3-(4-溴-3-氟苯基-5-(羥甲基)惡唑烷-2-酮 |
1369530-77-7 |
詳細(xì)
|
| Benzyl (4-broMo-3-fluorophenyl)carbaMate |
4-溴-3-氟苯基氨基甲酸芐酯 |
510729-01-8 |
詳細(xì)
|
| Ceffuroxime GSK1685761A impurities |
頭孢呋辛GSK1685761A雜質(zhì) |
|
詳細(xì)
|
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester |
(3R,4S)-3-(2-溴乙?；?-4-乙基-1-吡咯烷羧酸芐酯 |
1428243-26-8 |
詳細(xì)
|
| (-)-NORGESTREL 98 |
右旋炔諾孕酮(炔諾孕酮右旋體) |
797-64-8 |
詳細(xì)
|
| 3-Cyclohexene-1-methanol Methanesulfonate |
3-環(huán)己烯-1-甲醇甲磺酸鹽 |
108541-48-6 |
詳細(xì)
|
| Benzoxazole, 2,2'-oxybis- |
2,2'-氧基雙(苯并[d]惡唑) |
1195164-35-2 |
詳細(xì)
|
| Brexpiprazole BPZ-43 control |
布瑞哌唑BPZ-43對照品 |
2059942-13-9 |
詳細(xì)
|
| Cefuroxime Impurity |
頭孢呋辛氧化雜質(zhì) |
929531-94-2 |
詳細(xì)
|
| (2S,3aR,7aS)-Octahydro-1H-indole-2-carboxylic acid |
(2S,3aR,7aS)-1H-八氯吲哚-2-羧酸 |
145438-94-4 |
詳細(xì)
|
| Alverine |
阿爾維林 |
150-59-4 |
詳細(xì)
|
| Nitroso Labetalol |
亞硝基拉貝洛爾 |
2820170-74-7 |
詳細(xì)
|
| Nicotine EP Impurity G |
尼古丁EP雜質(zhì)G |
494-52-0 |
詳細(xì)
|
| Nicotine EP Impurity D |
尼古丁EP雜質(zhì)D |
532-12-7 |
詳細(xì)
|
| 5-Chlorovaleric acid |
5-氯戊酸 |
1119-46-6 |
詳細(xì)
|
| Benzenesulfonamide, 2-methoxy-5-[(2S)-2-[[(1R)-1-phenylethyl]amino]propyl]- |
2-甲氧基-5-（（S）-2-（（（R）-1-苯乙基）氨基）丙基）苯磺酰胺 |
2458209-31-7 |
詳細(xì)
|
| Benzene, 1-(2-bromoethoxy)-4-ethoxy- |
2-(4-乙氧基苯氧基)溴乙烷 |
54646-18-3 |
詳細(xì)
|
| (M1-Impurity C)4-acetamido-3,5-dichloro-2-methoxybenzoate methyl ester |
(M1-雜質(zhì)C)4-乙酰氨基-3,5-二氯-2-甲氧基苯甲酸甲酯 |
111049-74-2 |
詳細(xì)
|
| Sucrose Heptasulfate, Potassium Salt |
蔗糖七硫酸酯鉀 |
386229-69-2 |
詳細(xì)
|